These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2219388)

  • 1. New immunosuppressive agents in experimental allogeneic heart transplantation.
    Walter P; Bernhard U; Menger M; Keller HE; Schorlemmer HU; Feifel G
    Transplant Proc; 1990 Oct; 22(5):2324. PubMed ID: 2219388
    [No Abstract]   [Full Text] [Related]  

  • 2. Synergistic effect of 15-deoxyspergualin and cyclosporine in prolonging survival of rat cardiac allografts.
    Kaji H; Chou DT; Sutherland DE; Stephanian E; Gores PF
    Transplant Proc; 1994 Apr; 26(2):869-70. PubMed ID: 8171689
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunosuppressive mechanisms of 15-deoxyspergualin on heterotopic heart transplantation in rats.
    Nakata S; Ito T; Shirakura R; Matsuda H; Fukuzawa M; Nakano S; Fukushima N; Kawashima Y
    Transplant Proc; 1991 Feb; 23(1 Pt 1):864-5. PubMed ID: 1825004
    [No Abstract]   [Full Text] [Related]  

  • 4. 15-Deoxyspergualin potentiates the immunosuppressive effect of cyclosporine A in a rat heart allograft model.
    Gannedahl G; Wanders A; Carlsson M; Tufveson G
    Transplant Proc; 1993 Feb; 25(1 Pt 1):768-9. PubMed ID: 8438473
    [No Abstract]   [Full Text] [Related]  

  • 5. Beneficial effect of 15-deoxyspergualin on accelerated rejection in rat heart transplantation.
    Ueda H; Itoh S; Kusaka M; Isurugi K
    Transplant Proc; 1995 Feb; 27(1):420-2. PubMed ID: 7879046
    [No Abstract]   [Full Text] [Related]  

  • 6. Mode of action of immunosuppressive drugs evaluated with the aid of the immunostimulator LS-2616: studies on rejecting rat cardiac allografts.
    Wanders A; Gannedahl G; Gerdin B; Tufveson G
    Transplant Proc; 1992 Feb; 24(1):274-5. PubMed ID: 1539280
    [No Abstract]   [Full Text] [Related]  

  • 7. 15-Deoxyspergualin inhibits antibody production in mouse to rat heart transplantation.
    Gannedahl G; Karlsson-Parra A; Tötterman TH; Tufveson G
    Transplant Proc; 1993 Feb; 25(1 Pt 1):778-80. PubMed ID: 8438478
    [No Abstract]   [Full Text] [Related]  

  • 8. 15-Deoxyspergualin and mouse to rat heart retransplantation.
    Gannedahl G; Karlsson-Parra A; Tötterman TH; Tufveson G
    Transplant Proc; 1992 Apr; 24(2):710-1. PubMed ID: 1566493
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of 15-deoxyspergualin on hamster-to-rat cardiac xenograft survival.
    Pruitt SK; Halperin EC; Bollinger RR
    Transplant Proc; 1991 Feb; 23(1 Pt 1):585-6. PubMed ID: 1990618
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy of leflunomide in combination with current immunosuppressive agents in rat cardiac allotransplantation.
    Candinas D; Achilleos O; Lee SJ; Dalgic A; Mayer AD; Buckels JA; McMaster P; D'Silva M
    Transplant Proc; 1994 Dec; 26(6):3251-2. PubMed ID: 7527959
    [No Abstract]   [Full Text] [Related]  

  • 11. Natural antibody production can be inhibited by 15-deoxyspergualin in a discordant xenograft model.
    Flores HC; Leventhal JR; Gruber SA; Figueroa J; Platt JL; Manivel C; Bach FH; Matas AJ; Bolman RM
    Transplant Proc; 1992 Apr; 24(2):714. PubMed ID: 1566495
    [No Abstract]   [Full Text] [Related]  

  • 12. Synergism of splenectomy and immunosuppressive drugs in prolongation of cardiac xenograft survival.
    Carobbi A; Araneda D; Quarantillo P; Thomas JM; Thomas FT
    Transplant Proc; 1992 Apr; 24(2):527. PubMed ID: 1373543
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibitory effect of 15-deoxyspergualin on coronary arteriosclerosis in the transplanted heart.
    Hachida M; Zhang X; Lu H; Hoshi H; Koyanagi H
    Transplant Proc; 1999; 31(1-2):143-6. PubMed ID: 10083050
    [No Abstract]   [Full Text] [Related]  

  • 14. Prolongation of graft survival by pretransplant administration of donor spleen cells and 15-deoxyspergualin.
    Suzuki S; Shimatani K; Hayashi R; Kenmochi T; Fukuoka T; Amemiya H
    Transplant Proc; 1990 Aug; 22(4):1624-5. PubMed ID: 2389426
    [No Abstract]   [Full Text] [Related]  

  • 15. Therapy with 15-deoxyspergualin and total lymphoid irradiation blocks xenograft rejection and antibody formation after xenografting.
    Marchman W; Araneda D; DeMasi R; Taylor D; Carobbi A; Larkin E; Alqaisi M; Thomas F
    Transplant Proc; 1991 Feb; 23(1 Pt 1):210-1. PubMed ID: 1990515
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunosuppressive effect of brequinar on rat cardiac allograft survival in combination with leflunomide or FK 506.
    D'Silva M; Antoniou E; DeRoover A; Nishimura Y; Howie A; McMaster P
    Transplant Proc; 1996 Apr; 28(2):950-1. PubMed ID: 8623476
    [No Abstract]   [Full Text] [Related]  

  • 17. Difference in immunosuppressive effects of antibodies to ICAM-1 and LFA-1 between hepatic and cardiac allografts.
    Harihara Y; Sugawara Y; Inoue K; Kubota K; Bandai Y; Makuuchi M; Miyasaka M
    Transplant Proc; 1996 Jun; 28(3):1368-9. PubMed ID: 8658698
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of interferon alpha/beta on cardiac allografts.
    Harihara Y; Sugawara Y; Inoue K; Kubota K; Bandai Y; Makuuchi M
    Transplant Proc; 1996 Jun; 28(3):1250-1. PubMed ID: 8658645
    [No Abstract]   [Full Text] [Related]  

  • 19. SK&F 105685: a novel immunosuppressive compound with efficacy in animal models of autoimmunity and transplantation.
    Badger AM; Albrightson-Winslow CR; Kupiec-Weglinski JW
    Transplant Proc; 1991 Feb; 23(1 Pt 1):194-5. PubMed ID: 1990512
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunosuppressive effects of ursodeoxycholic acid in heart-allografted rats.
    Bährle S; Szabó G; Dengler TJ; Zimmermann R; Hagl S; Kübler W
    Transplant Proc; 1998 May; 30(3):864-5. PubMed ID: 9595128
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.